SCHEMBL6581289

SCHEMBL6581289

Cn1nc(-c2ccc(OC(F)F)cc2)nc1-c1cccc(C=O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 2/20 0.46
NR1H2 P55055 2/20 0.44
NR1H3 Q13133 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
HSD17B2 P37059 1/20 0.42
KDM4C Q9H3R0 2/20 0.38
NPSR1 Q6W5P4 3/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 2/20 0.38
GAA P10253 2/20 0.38
HPGD P15428 2/20 0.38
HTT P42858 2/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
BLM P54132 1/20 0.38
GRM2 Q14416 1/20 0.36
MAT2A P31153 1/20 0.36
AOC3 Q16853 2/20 0.36
TDP2 O95551 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6580839 0.86 KDM4C (0.49) NR1H2NR1H3NPC1RAB9AHSD17B2
SCHEMBL6581144 0.83 NR1H2 (0.53) NR1H2NR1H3NPC1RAB9AHSD17B2
SCHEMBL6578492 0.83 NR1H2 (0.47) NR1H2NR1H3NPC1RAB9AHSD17B2
SCHEMBL6578166 0.81 HSD17B2 (0.51) NR1H2NR1H3NPC1RAB9AHSD17B2
Pyrrolidine SCHEMBL6582654 0.79 KDM4C (0.43) NR1H2NR1H3NPC1RAB9AHSD17B2
SCHEMBL6580791 0.78 TNK2 (0.43) NR1H2NR1H3NPC1RAB9AHSD17B2
SCHEMBL6578551 0.78 NPC1 (0.39) DRD1NR1H2NR1H3NPC1RAB9A
SCHEMBL8367047 0.78 DRD1 (0.72) DRD1NPC1RAB9AALDH1A1MAPT
Hydrochloric Acid SCHEMBL6583998 0.78 TNK2 (0.42) NR1H2NR1H3NPC1RAB9AHSD17B2
SCHEMBL6580847 0.77 TDP2 (0.44) NR1H2NR1H3NPC1RAB9AHSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070708-B1 Triazole derivatives HOFFMANN LA ROCHE (CH) 2004-01-14 EP disclosed
US-6265426-B1 CENTRAL NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. 2001-07-24 US disclosed
EP-1070708-A1 Triazole and imidazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2001-01-24 EP disclosed